Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy, Safety, Tolerability of Neramexane in Patients With Subjective Tinnitus
This study has been completed.
Study NCT00955799   Information provided by Merz Pharmaceuticals GmbH

First Received on August 6, 2009.   Last Updated on November 27, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Subjective Tinnitus
Additional conditions recognized in this trial
Tinnitus
More general conditions related to this trial
Ear Diseases
Hearing Disorders
Nervous System Diseases
Neurologic Manifestations
Otorhinolaryngologic Diseases
Sensation Disorders
Signs and Symptoms
Interventions listed in this trial
Neramexane mesylate
Placebo
Sponsors listed in this trial
Merz Pharmaceuticals GmbH


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services